Metagenomi to Present at Chardan’s 8th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing […]
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing […]
Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously […]
AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results […]
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cayson Acquisition Corp (the “Company”) announced today that it priced its initial […]
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed […]
New York, NY, Sept. 19, 2024 (GLOBE NEWSWIRE) — YHN Acquisition I Limited (the “Company”) announced today the closing of […]
WHITE PLAINS, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (the “Company”) (NasdaqCM: NECB) announced today that […]
SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on […]
GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today […]